Amgen Requests Hearing on FDA Proposal to Withdraw Approval of TAVNEOS for Rare Disease Treatment
2026-06-14
PubComNonGov2026-06-14
Carter Struck
WASHINGTON, June 14 -- Amgen Inc. of Thousand Oaks, California has submitted a public comment letter to the U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER) opposing . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, June 14 -- Amgen Inc. of Thousand Oaks, California has submitted a public comment letter to the U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER) opposing . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026